Alan D Frazier's Net Worth
$345 Million
Who is Alan D Frazier?
Alan D Frazier has an estimated net worth of $345 Million. This is based on reported shares across multiple companies, which include Alexza Pharmaceuticals Inc., GLAUKOS Corp, COLLEGIUM PHARMACEUTICAL, INC, ANAPTYSBIO INC, Sierra Oncology, Inc., RIGEL PHARMACEUTICALS INC, and CADENCE PHARMACEUTICALS INC.
SEC CIK
Alan D Frazier's CIK is 0001018534
Past Insider Trading and Trends
2017 was Alan D Frazier's most active year for acquiring shares with 16 total transactions. Alan D Frazier's most active month to acquire stocks was the month of December. 2017 was Alan D Frazier's most active year for disposing of shares, totalling 12 transactions. Alan D Frazier's most active month to dispose stocks was the month of December. 2017 saw Alan D Frazier paying a total of $13,066,838.50 for 7,376,894 shares, this is the most they've acquired in one year. In 2004 Alan D Frazier cashed out on 1,763,559 shares for a total of $5,983,207.19, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alexza Pharmaceuticals Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +118.06% | 21.01K |
—
|
—
| 38.8K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
∞
| 17.79K |
—
|
—
| 17.79K |
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
∞
| 2.18M |
—
|
—
| 2.18M |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GLAUKOS Corp (GKOS) Snapshot price: $94.305
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.6M |
—
|
—
| 2.6M |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.265
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.89M |
$12.00 |
—
| 1.89M |
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANAPTYSBIO INC (ANAB) Snapshot price: $23.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -58.49% | -1.37M |
—
|
—
| 973.61K |
May 11
| |||
Form 4
| -58.49% | -1.37M |
—
|
—
| 973.61K |
May 11
| |||
Form 4
| +5.26% | 117.23K |
$4.55 | $533,419.25 | 2.35M |
Feb 2
| |||
Form 4
| +5.26% | 117.23K |
$4.55 | $533,419.25 | 2.35M |
Feb 2
| |||
Form 4
|
∞
| 3.57M |
$15.00 | $6,000,000.00 | 3.57M |
Jan 31
| |||
Form 4
|
∞
| 3.57M |
$15.00 | $6,000,000.00 | 3.57M |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||